YC W23
Adventris Pharmaceuticals
Adventris makes cancer vaccines
About
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Founders
- Jen Herbach
- Mark Yarchoan
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Adventris Pharmaceuticals.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryBiotechTherapeuticsDrug discoveryOncology